Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Surg Pathol. 2016 Dec;40(12):e94–e102. doi: 10.1097/PAS.0000000000000749

Table 1.

Surveillance, Epidemiology and End Results Program: Unique Analyses and Critical Insights

Analyses Critical Insights

  1. Population-based cancer rates

  2. Rare cancer rates

  3. Cancers rates in minority groups

  4. Birth-cohort effect

  5. Calendar-period effect

  6. Risk modelling

  7. Oncology practice and biomarker utilization

  1. Absolute risk of cancer occurrence

  2. Precise and comprehensive description

  3. Health disparity assessments

  4. Risk factor exposure assessments

  5. Benefits/harms of screening

  6. Individual’s risk of a particular cancer

  7. Therapeutic targets and diagnostic, predictive and prognostic markers.